Zenmak Nutrigencies And Health Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.35 Cr
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
- Revenue Growth 22.62%
- Profit Growth 2.12%
- Ebitda 34.27%
- Net Worth 103.70%
- Total Assets 35.33%
About Zenmak Nutrigencies And Health
Zenmak Nutrigencies And Health Private Limited (ZNAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2017 (Seven years and seven months 26 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹1.50 Cr.
Lazar Dayaladas and Karuppanagounder Muthuswamy serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909TN2017PTC117326
- Company No.
117326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Zenmak Nutrigencies And Health?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lazar Dayaladas  | Additional Director | 20-Jul-2024 | Current |
| Karuppanagounder Muthuswamy | Director | 29-Jun-2017 | Current |
Financial Performance of Zenmak Nutrigencies And Health.
Zenmak Nutrigencies And Health Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.62% increase. The company also saw a slight improvement in profitability, with a 2.12% increase in profit. The company's net worth Soared by an impressive increase of 103.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenmak Nutrigencies And Health?
In 2021, Zenmak Nutrigencies And Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Concord Farma LlpKaruppanagounder Muthuswamy is a mutual person
Charges (Loans)
₹1.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2023 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Zenmak Nutrigencies And Health?
Zenmak Nutrigencies And Health has a workforce of 8 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenmak Nutrigencies And Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenmak Nutrigencies And Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
